Alopecia Clinical Trials

A listing of Alopecia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Arizona

Tucson Arizona 85724

A clinical trial to evaluate treatments using 7% (w/v) Tempol alcohol-based gel (MTS-01) and alcohol-based gel for patients with Alopecia

Arkansas

Hot Springs Arkansas 71913

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Little Rock Arkansas 72205

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

California

Irvine California 92618

A clinical trial seeking patients for a research study for the treatment of Alopecia Areata or Scarring Alopecia

Irvine California 92618

A clinical trial seeking patients for a research study for the treatment of Hair Disease

Irvine California 92697

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Androgenic Alopecia

Rancho Mirage California 92270

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

View More ▼

Redwood City California 94064

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

San Diego California 92123

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Santa Monica California 90404

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Santa Rosa California 95405

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Connecticut

New Haven Connecticut 06519

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

New Haven Connecticut 06519

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

View More ▼

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Florida

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Tampa Florida 33609

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Tampa Florida 33609

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Georgia

Newnan Georgia 30263

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Illinois

Chicago Illinois 60611

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Skokie Illinois 60077

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Indiana

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Kansas

Wichita Kansas 67207

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Massachusetts

Boston Massachusetts 02111

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Michigan

Clinton Michigan 48038

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Minnesota

Fridley Minnesota 55432

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Fridley Minnesota 55432

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Montana

Stevensville Montana 59870

A clinical trial seeking patients for a research study for the treatment of Alopecia Areata or Scarring Alopecia

New York

Mount Sinai Medical Center
New York New York 10029

An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

Sadick Research Group
New York New York 10075

Study to Evaluate Safety and Efficacy of a Nutraceutical Supplement with Standardized Botanicals for Treatment of Hair Loss and Thinning in Females

View More ▼

New York New York 10029

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Rochester New York 14642

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Rochester New York 14642

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

North Carolina

Winston-Salem North Carolina 27157

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Ohio

Cleveland Ohio 44195

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Oklahoma

Tulsa Oklahoma 74136-7028

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Oregon

Portland Oregon 97210

A clinical trial to evaluate treatments using CTP-543 and Placebo for patients with Alopecia Areata

Portland Oregon 97210

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Portland Oregon 97223

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Pennsylvania

Hershey Pennsylvania 17033

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Philadelphia Pennsylvania 19104

A clinical trial to evaluate treatments using 7% (w/v) Tempol alcohol-based gel (MTS-01) and alcohol-based gel for patients with Alopecia

South Carolina

Greer South Carolina 29650

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia